Logo image of LNTH

LANTHEUS HOLDINGS INC (LNTH) Stock Fundamental Analysis

USA - NASDAQ:LNTH - US5165441032 - Common Stock

52.7 USD
-1.13 (-2.1%)
Last: 10/6/2025, 8:37:32 PM
52.7 USD
0 (0%)
After Hours: 10/6/2025, 8:37:32 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to LNTH. LNTH was compared to 191 industry peers in the Health Care Equipment & Supplies industry. LNTH scores excellent points on both the profitability and health parts. This is a solid base for a good stock. LNTH is valued quite cheap, while showing a decent growth score. This is a good combination! With these ratings, LNTH could be worth investigating further for value and quality investing!.


Dividend Valuation Growth Profitability Health

Quickly go to:

9

1. Profitability

1.1 Basic Checks

LNTH had positive earnings in the past year.
LNTH had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: LNTH reported negative net income in multiple years.
LNTH had a positive operating cash flow in each of the past 5 years.
LNTH Yearly Net Income VS EBIT VS OCF VS FCFLNTH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

LNTH's Return On Assets of 12.81% is amongst the best of the industry. LNTH outperforms 94.24% of its industry peers.
Looking at the Return On Equity, with a value of 23.23%, LNTH belongs to the top of the industry, outperforming 95.81% of the companies in the same industry.
LNTH's Return On Invested Capital of 18.03% is amongst the best of the industry. LNTH outperforms 96.86% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for LNTH is significantly above the industry average of 9.00%.
The 3 year average ROIC (16.25%) for LNTH is below the current ROIC(18.03%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 12.81%
ROE 23.23%
ROIC 18.03%
ROA(3y)12.56%
ROA(5y)5.58%
ROE(3y)25.01%
ROE(5y)11.41%
ROIC(3y)16.25%
ROIC(5y)N/A
LNTH Yearly ROA, ROE, ROICLNTH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300 400 500

1.3 Margins

The Profit Margin of LNTH (17.82%) is better than 93.19% of its industry peers.
LNTH's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 28.64%, LNTH belongs to the best of the industry, outperforming 95.81% of the companies in the same industry.
LNTH's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 63.75%, LNTH is in the better half of the industry, outperforming 65.97% of the companies in the same industry.
In the last couple of years the Gross Margin of LNTH has grown nicely.
Industry RankSector Rank
OM 28.64%
PM (TTM) 17.82%
GM 63.75%
OM growth 3YN/A
OM growth 5Y14.46%
PM growth 3YN/A
PM growth 5Y17.41%
GM growth 3Y13.43%
GM growth 5Y5.06%
LNTH Yearly Profit, Operating, Gross MarginsLNTH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so LNTH is creating value.
The number of shares outstanding for LNTH remains at a similar level compared to 1 year ago.
The number of shares outstanding for LNTH has been increased compared to 5 years ago.
Compared to 1 year ago, LNTH has an improved debt to assets ratio.
LNTH Yearly Shares OutstandingLNTH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
LNTH Yearly Total Debt VS Total AssetsLNTH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

LNTH has an Altman-Z score of 4.58. This indicates that LNTH is financially healthy and has little risk of bankruptcy at the moment.
LNTH has a better Altman-Z score (4.58) than 76.44% of its industry peers.
LNTH has a debt to FCF ratio of 1.19. This is a very positive value and a sign of high solvency as it would only need 1.19 years to pay back of all of its debts.
LNTH has a Debt to FCF ratio of 1.19. This is amongst the best in the industry. LNTH outperforms 91.10% of its industry peers.
A Debt/Equity ratio of 0.49 indicates that LNTH is not too dependend on debt financing.
LNTH has a Debt to Equity ratio (0.49) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 1.19
Altman-Z 4.58
ROIC/WACC2.3
WACC7.85%
LNTH Yearly LT Debt VS Equity VS FCFLNTH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

LNTH has a Current Ratio of 4.29. This indicates that LNTH is financially healthy and has no problem in meeting its short term obligations.
LNTH's Current ratio of 4.29 is fine compared to the rest of the industry. LNTH outperforms 72.25% of its industry peers.
A Quick Ratio of 4.07 indicates that LNTH has no problem at all paying its short term obligations.
LNTH has a better Quick ratio (4.07) than 76.44% of its industry peers.
Industry RankSector Rank
Current Ratio 4.29
Quick Ratio 4.07
LNTH Yearly Current Assets VS Current LiabilitesLNTH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

5

3. Growth

3.1 Past

The earnings per share for LNTH have decreased by -4.77% in the last year.
The Earnings Per Share has been growing by 42.10% on average over the past years. This is a very strong growth
LNTH shows a small growth in Revenue. In the last year, the Revenue has grown by 5.75%.
Measured over the past years, LNTH shows a very strong growth in Revenue. The Revenue has been growing by 34.59% on average per year.
EPS 1Y (TTM)-4.77%
EPS 3Y140.07%
EPS 5Y42.1%
EPS Q2Q%-12.78%
Revenue 1Y (TTM)5.75%
Revenue growth 3Y53.37%
Revenue growth 5Y34.59%
Sales Q2Q%-4.07%

3.2 Future

LNTH is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.19% yearly.
LNTH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.10% yearly.
EPS Next Y-14.37%
EPS Next 2Y-6.06%
EPS Next 3Y1.33%
EPS Next 5Y4.19%
Revenue Next Year-2.45%
Revenue Next 2Y0.19%
Revenue Next 3Y4.31%
Revenue Next 5Y5.1%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
LNTH Yearly Revenue VS EstimatesLNTH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B
LNTH Yearly EPS VS EstimatesLNTH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2 4 6 8

More info and screens

8

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 8.25, the valuation of LNTH can be described as reasonable.
95.29% of the companies in the same industry are more expensive than LNTH, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of LNTH to the average of the S&P500 Index (27.90), we can say LNTH is valued rather cheaply.
The Price/Forward Earnings ratio is 8.81, which indicates a very decent valuation of LNTH.
LNTH's Price/Forward Earnings ratio is rather cheap when compared to the industry. LNTH is cheaper than 96.34% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.36, LNTH is valued rather cheaply.
Industry RankSector Rank
PE 8.25
Fwd PE 8.81
LNTH Price Earnings VS Forward Price EarningsLNTH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LNTH indicates a rather cheap valuation: LNTH is cheaper than 96.34% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, LNTH is valued cheaper than 97.91% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.49
EV/EBITDA 6.96
LNTH Per share dataLNTH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The excellent profitability rating of LNTH may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.2
EPS Next 2Y-6.06%
EPS Next 3Y1.33%

More info and screens

0

5. Dividend

5.1 Amount

LNTH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LANTHEUS HOLDINGS INC

NASDAQ:LNTH (10/6/2025, 8:37:32 PM)

After market: 52.7 0 (0%)

52.7

-1.13 (-2.1%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)10-30 2025-10-30/bmo
Inst Owners117.2%
Inst Owner Change0%
Ins Owners1.26%
Ins Owner Change-1.88%
Market Cap3.58B
Analysts81.05
Price Target88.82 (68.54%)
Short Float %11.21%
Short Ratio4.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.82%
Min EPS beat(2)-9.67%
Max EPS beat(2)-7.97%
EPS beat(4)2
Avg EPS beat(4)-2.24%
Min EPS beat(4)-9.67%
Max EPS beat(4)7.07%
EPS beat(8)5
Avg EPS beat(8)2.73%
EPS beat(12)9
Avg EPS beat(12)9.01%
EPS beat(16)13
Avg EPS beat(16)19.34%
Revenue beat(2)0
Avg Revenue beat(2)-4.16%
Min Revenue beat(2)-4.74%
Max Revenue beat(2)-3.58%
Revenue beat(4)1
Avg Revenue beat(4)-1.57%
Min Revenue beat(4)-4.74%
Max Revenue beat(4)2.13%
Revenue beat(8)4
Avg Revenue beat(8)0.01%
Revenue beat(12)8
Avg Revenue beat(12)1.39%
Revenue beat(16)12
Avg Revenue beat(16)4.04%
PT rev (1m)-3.41%
PT rev (3m)-32.66%
EPS NQ rev (1m)-0.23%
EPS NQ rev (3m)-23.81%
EPS NY rev (1m)-0.31%
EPS NY rev (3m)-14.86%
Revenue NQ rev (1m)0.1%
Revenue NQ rev (3m)-8.27%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)-5.79%
Valuation
Industry RankSector Rank
PE 8.25
Fwd PE 8.81
P/S 2.36
P/FCF 7.49
P/OCF 6.79
P/B 3.07
P/tB 5.69
EV/EBITDA 6.96
EPS(TTM)6.39
EY12.13%
EPS(NY)5.98
Fwd EY11.35%
FCF(TTM)7.04
FCFY13.36%
OCF(TTM)7.76
OCFY14.72%
SpS22.37
BVpS17.16
TBVpS9.27
PEG (NY)N/A
PEG (5Y)0.2
Profitability
Industry RankSector Rank
ROA 12.81%
ROE 23.23%
ROCE 23.72%
ROIC 18.03%
ROICexc 29.02%
ROICexgc 54.83%
OM 28.64%
PM (TTM) 17.82%
GM 63.75%
FCFM 31.47%
ROA(3y)12.56%
ROA(5y)5.58%
ROE(3y)25.01%
ROE(5y)11.41%
ROIC(3y)16.25%
ROIC(5y)N/A
ROICexc(3y)32.43%
ROICexc(5y)N/A
ROICexgc(3y)46.23%
ROICexgc(5y)N/A
ROCE(3y)21.38%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y26.32%
ROICexc growth 3YN/A
ROICexc growth 5Y20.97%
OM growth 3YN/A
OM growth 5Y14.46%
PM growth 3YN/A
PM growth 5Y17.41%
GM growth 3Y13.43%
GM growth 5Y5.06%
F-Score5
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 1.19
Debt/EBITDA 1.14
Cap/Depr 79.81%
Cap/Sales 3.21%
Interest Coverage 250
Cash Conversion 106.19%
Profit Quality 176.61%
Current Ratio 4.29
Quick Ratio 4.07
Altman-Z 4.58
F-Score5
WACC7.85%
ROIC/WACC2.3
Cap/Depr(3y)104.83%
Cap/Depr(5y)78.74%
Cap/Sales(3y)4.75%
Cap/Sales(5y)4.15%
Profit Quality(3y)383.97%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.77%
EPS 3Y140.07%
EPS 5Y42.1%
EPS Q2Q%-12.78%
EPS Next Y-14.37%
EPS Next 2Y-6.06%
EPS Next 3Y1.33%
EPS Next 5Y4.19%
Revenue 1Y (TTM)5.75%
Revenue growth 3Y53.37%
Revenue growth 5Y34.59%
Sales Q2Q%-4.07%
Revenue Next Year-2.45%
Revenue Next 2Y0.19%
Revenue Next 3Y4.31%
Revenue Next 5Y5.1%
EBIT growth 1Y-3.87%
EBIT growth 3YN/A
EBIT growth 5Y54.05%
EBIT Next Year-12.91%
EBIT Next 3Y3.09%
EBIT Next 5YN/A
FCF growth 1Y95.83%
FCF growth 3Y123.25%
FCF growth 5Y51.49%
OCF growth 1Y91.73%
OCF growth 3Y116.21%
OCF growth 5Y46.62%